Cubist Systematic Strategies, LLC Sesen Bio, Inc. Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.49 - $0.61 $7,750 - $9,648	15,817 New	15,817 $9,000
Q2 2022 Aug 15, 2022	BUY	$0.38 - $0.89 $7,016 - $16,433	18,465 New	18,465 $15,000
Q3 2021 Nov 15, 2021	SELL	$0.77 - $4.91 $218,257 - $1.39 Million	-283,451 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.18 - $4.66 $809,183 - $1.73 Million	-371,185 Reduced 56.7%	283,451 $1.31 Million
Q1 2021 May 17, 2021	BUY	$1.3 - $3.24 $851,026 - $2.12 Million	654,636 New	654,636 $1.7 Million

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.